Freyr assisted a US-based pharmaceutical company submit its Complete Response Letter (CRL) to the United States Food and Drug Administration (US FDA).
The company faced challenges and anticipated a late submission. Freyr guided the client and provided end-to-end support, from compilation to the submission of the CRL report via electronic submission gateway (ESG).
Download the proven case to learn how Freyr’s RA team assisted the customer with this project.
Fill the form below to download the Case Study
